and understand and hence, reverse this process, it is essential to R.A.Hipskind 3 identify the factors capable of potentiating the transition to cancerous growth through complementation of the activated 
To whom correspondence should be addressed that are coupled to heterotrimeric G-proteins and (ii) P2X, In the human breast cancer cell line MCF-7, the nucleotides ligand-gated ion channels (1) . Extracellular ATP, which activ-ATP γS and UTP, acting extracellularly through the purates P2Y 1 and P2Y 2 receptors, synergizes with growth factors inergic receptor P2Y 2 , lead to elevated intracellular calcium to induce mitogenesis in non-transformed smooth muscle cells, levels and increased proliferation. ATP γS and UTP treatendothelial cells and astrocytes (2) (3) (4) . In the breast cancer cell ment of MCF-7 cells activated transcription of the immediline MCF-7, ATP and UTP elevate intracellular calcium and ate early gene c-fos, an important component in the stimulate proliferation via activation of the P2Y 2 receptor (5). response to proliferative stimulation. c-fos induction was A variety of different signalling pathways could mediate enhanced by co-treatment with ATP γS and a variety these effects, since extracellular nucleotides lead to tyrosine of proliferative agents including growth factors, tumour phosphorylation of growth factor receptors (6) and activate promoters and stress. Stimulation with ATP γS or epidermal the ERK cascade (7), phosphatidyl inositol 3-kinase (8) , protein growth factor (EGF) led to extracellular signal-regulated kinase A (9) and other Ca 2ϩ -dependent pathways depending kinase (ERK) activation and phosphorylation of the upon the cell type (10) . transcription factors CREB and Elk-1. Co-stimulation An important component in the response to proliferative synergistically activated fos expression and notably led signals is the rapid, transient transcriptional activation of to increased levels of ERK, CREB and EGF receptor immediate early genes, such as the c-fos proto-oncogene. c-fos phosphorylation, as well as hyperphosphorylation of expression is regulated at multiple levels by intracellular ternary complex factor. Nevertheless, the ERK pathway signalling events, which makes it a useful paradigm to identify does not fully account for this synergy, since fos induction and characterize factors that affect cancer cell growth. This is was differentially sensitive to the MEK inhibitor U0126, particularly relevant in breast cancer models, since the expresindicating that these two agonists signal differently to this sion of c-fos antisense RNA inhibits growth of MCF-7 tumours immediate early gene. Thus, extracellular nucleotides coin athymic mice (11) . operate with growth factors to activate genes linked to the Extensive studies have linked distinct elements in the c-fos proliferative response in MCF-7 cells through activation promoter to different signal transduction modules through the of specific purinergic receptors, which thereby represent phosphorylation of transcription factors that interact with important potential targets for arresting the neoplastic regulatory sites. Less well characterized is c-fos induction progression of breast cancer cells.
resulting from synergy between different signals, as appears to be the case with extracellular nucleotides. We have recently Introduction shown that nucleotide-induced c-fos activation in human osteosarcoma cells is strongly enhanced by co-treatment with Cell proliferation is controlled by a complex intracellular parathyroid hormone (10) . This synergy represented a novel signalling network whose disruption is strongly linked to example of distinct intracellular signalling pathways activating neoplastic transformation. This is well characterized for the different regulatory elements in the c-fos promoter. This led pathway that links growth-factor activated receptors to the us to investigate the effects of extracellular nucleotides alone Ras/Raf/extracellular signal-regulated kinase (ERK) signalling and in combination with growth factors on c-fos induction in cascade, where a number of its components are found mutated the breast cancer cell line MCF-7. We find that ATP γS and in a wide variety of cancers. Accordingly, these mutant proteins epidermal growth factor (EGF) alone lead to moderate increases can function as potent oncogenes when over-expressed in vivo in c-fos mRNA levels, but together they synergistically activate and in vitro. However, focus formation and tumorigenesis is c-fos. activation. 
Materials and methods

Nuclear extract preparation and gel retardation assays
MCF-7 cells were challenged for 10 min with agonist before preparation of nuclear extracts as previously described (28) . Gel retardation assays were performed according to established protocols (10) . Core SRF 90-244 was produced in HeLa cells using a recombinant vaccina virus (29). The probe corresponded to the c-fos SRE subcloned in front of a G-free cassette plasmid (30). After digestion with EcoRI and NarI, the ends were labelled by a Klenow fill-in reaction containing [α-32 P]dATP and cold dCTP, dGTP and dTTP fragments. Fragments were isolated from polyacrylamide gels by electroelution.
Northern analysis
Ten micrograms of total RNA was electrophoresed through a 0.8% (w/v) agarose-formaldehyde gel and transferred to Zetabind hybridization membrane according to the manufacturer's protocol. Blots were prehybridized in 50% formamide, 5ϫ SSC, 5ϫ Denhardt's, 50 mM NaHPO 4 , pH 6.8, 1% SDS, 5 mg/ml total calf liver RNA, 5 mg/ml Torula tRNA for 30 min at 65°C and probed with [ 32 P]UTP-labelled riboprobes specific for the antisense strand of Fig. 2 . Specific induction of c-fos mRNA by P2Y 2 receptor agonists. human c-fos exons 3 and 4 and either rat gapdh or ief-4α (31) as the internal Quiescent MCF-7 cells were either untreated (vehicle) or treated as control. Membranes were washed for 30 min in 0.2ϫ SSC/1% SDS at indicated above each lane, for 45 min. The northern blot was hybridized as 65°C and mRNA was visualized using phosphor storage technology and indicated in the legend to Figure 1 , except that RNA integrity and loading autoradiography with Kodak XAR film and intensifying screens at -70°C.
were confirmed by ethidium bromide staining (lower panel) to identify the Phosphorimager scans were quantified using ImageQuant (Molecular two major rRNAs, and by hybridization with the housekeeping gene ief4-α Dynamics) and standardized to the internal control.
(data not shown).
Western analysis
To obtain whole protein cell extracts for western analysis, cells were challenged
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with agonist for 10 min before extraction in Laemlli loading buffer. Fifteen
ATP strongly induces c-fos gene expression in MCF-7 breast
micrograms of cell extract were separated by SDS-PAGE on a 9% (w/v) minigel and electrotransferred to PVDF using the Milliblot-SDE system cancer cells (Millipore) at 0.6 mA/cm 2 for 1 h. Membranes were blocked with 5% (w/v) Stimulation of MCF-7 cells with ATP γS led to a dosenon-fat dry milk in 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1% Tween dependent induction of c-fos mRNA ( Figure 1A ). Treatment and UTP (1) . To confirm that induction of c-fos mRNA by systems converging on the c-fos promoter. Activation of protein kinase A (14) or activation of CaMKs can result in activation, ATP γS resulted from P2Y 2 receptor activation, serum-starved MCF-7 cells were challenged with a range of P2 receptor by phosphorylation on Ser133, of the transcription factor CREB, and thereby targets the CaCRE (position -60 in the agonists. Both ATPγS and UTP (10 µM) strongly elevated c-fos mRNA levels (Figure 2 ), where UTP was clearly more c-fos promoter). Alternatively, extracellular ATP may lead to activation of the ERK signalling cascade and therefore signal effective. In contrast, neither the P2Y 1 receptor agonists ADP and 2MeSATP, nor the P2X receptor agonist αβ-MeATP to the c-fos SRE (position -300 in the c-fos promoter). significantly activated c-fos (Figure 2) . Equal loading and hybridization were confirmed by ethidium bromide staining to reveal 18S and 28S ribosomal RNAs (Figure 2 ) and hybridization with the housekeeping gene ief-4α (data not shown).
ATP potentiates EGF-induced c-fos transcription
Nucleotides can potentiate the proliferative effects of growth factors in a number of cell types. In order to determine if ATP potentiates growth factor-induced c-fos expression in MCF-7 breast cancer cells, we tested EGF, transforming growth factor β1 (TGFβ1) and synthetic human parathyroid hormone-related peptide (PTHrP ) alone and in combination with a submaximal concentration of ATPγS (10 -5 M) ( Figure 3A) . EGF induced an increase in c-fos mRNA similar to that seen with ATP γS alone, whereas in combination, these two agents strongly potentiated c-fos induction. In contrast to this striking effect, c-fos induction by the combination of TGFβ1 and ATP γS was no better than that by ATPγS alone, whilst costimulation with PTHrP and ATP γS elevated mRNA levels additively.
ATP strongly potentiates MAPK-driven transcription
In order to define the intermediates involved in ATP and EGF potentiation, we assessed the ability of a submaximal dose of ATP γS to potentiate c-fos induction in combination with activators of distinct intracellular signalling systems. The phorbol ester TPA activates protein kinase C and ERK in MCF-7 cells (12), calcium ionophore increases intracellular Ca 2ϩ levels and anisomycin activates both the SAPK/JNK and p38 MAPK stress signalling cascades (13), both of which can target the serum response element (SRE) via TCF phosphorylation (14). All three inducers strongly activated c-fos expression in MCF-7 cells ( Figure 3B ) and each was affected differently by co-stimulation with ATPγS. c-fos induction by anisomycin was clearly potentiated, while the effect was less strong with TPA. Nevertheless, it was more than additive, unlike the degree of stimulation seen with Ca 2ϩ ionophore and ATPγS. The latter effect clearly contrasts with that observed between EGF and ATPγS ( Figure 3A ) and underlines the significance of that synergy.
ATP and EGF induce phosphorylation and activation of ERK1 and ERK2 and the transcription factor CREB: differential sensitivity to MEK inhibitor U0126
ATP-induced increases in intracellular calcium levels may be linked to several different downstream intracellular signalling mine if ATP treatment of MCF-7 cells leads to CREB phosphorylation or ERK activation. Antisera have been developed CREB phosphorylation by EGF was sensitive to U0126. In that are highly specific for Ser133-phosphorylated CREB, as contrast, CREB phosphorylation by ATP γS was unaffected by well as for p44 (ERK1) and p42 (ERK2) doubly phosphorylated the inhibitor. Immunodetection with control antisera confirmed on Thr202 and Tyr204, the key step in the activation of these that induction did not affect the levels of ERK or CREB. two kinases. Extracts were prepared from stimulated MCF-7 c-fos activation by ATPγS is only partially sensitive to inhibicells, separated by sodium dodecyl sulfate-polyacrylamide tion of the ERK cascade gel electrophoresis (SDS-PAGE) and electroblotted on to ATP γS-induced CREB activation, unlike EGF, was not polyvinylidene difluoride (PVDF) membranes. Immobilized sensitive to inhibition by U0126, suggesting that ATP activates proteins were immunodetected with the phospho-specific anti-CREB and ultimately targets the c-fos CaCRE, via an sera ( Figure 4A and B) , which revealed that ATP γS treatment ERK-independent mechanism. We therefore investigated the strongly increased both CREB and ERK phosphorylation effect of U0126 on fos mRNA induction following treatment relative to the uninduced cell extracts. Likewise, EGF treatment with ATPγS and EGF. ATPγS and EGF activated c-fos also strongly increased both ERK and CREB phosphorylation.
alone and synergistically when combined. EGF-induced c-fos Notably, co-stimulation with ATP γS and EGF led to increased induction was completely inhibited by U0126, while the levels of phospho-ERK and phospho-CREB relative to those inhibitor only partially affected c-fos induction by ATPγS observed with either factor alone. To test the contribution of ( Figure 5A ). Similar results were obtained using the MEK the ERK pathway to CREB phosphorylation in our system, inhibitor PD98059 ( Figure 5B ). we treated MCF-7 cells with U0126, an inhibitor specific for ATP and EGF co-stimulation potentiates EGF receptor the ERK-activating kinase, MEK. Interestingly, ATP γS and phosphorylation EGF-induced ERK and CREB phosphorylation was differentially sensitive to the MEK inhibitor, U0126. U0126, as expected, G-protein-coupled receptors have been linked to MAPK pathways via activation of tyrosine kinases that phosphorylate blocked ERK phosphorylation by ATP γS and EGF. In addition, growth factor receptors. A more recent report has suggested that growth factor receptor phosphorylation links P2Y 2 receptor activation to ERK phosphorylation (6) . Consequently, we investigated whether EGF receptor phosphorylation occurred in response to nucleotide treatment, and whether co-stimulation with EGF and P2Y 2 receptor agonists resulted in elevated levels of EGF receptor phosphorylation. As expected, treatment with EGF alone led to increased levels of EGF receptor with 32 P-labelled SRE and core SRF . Protein-DNA complexes were resolved by electrophoresis in 5% polyacrylamide gels containing 0.5ϫ strongly potentiates transcriptional activation by TCF (14). Consequently, we have investigated the phosphorylation status of endogenous TCF following ATP γS and EGF stimulation. TCF can be visualized in bandshift assays where it forms a ternary complex on a 32 P-labelled SRE probe, together with a recombinant truncated version of SRF that spans the MADS box and neighbouring amino acids. Phosphorylation of TCF leads to slowed mobility of the ternary complexes, which can be seen in response to EGF, ATPγS and anisomycin but not PTHrP stimulation (Figure 7) . Interestingly, co-stimulation with both ATPγS and EGF appeared to result in TCF hyperphosphorylation, as indicated by a further mobility shift, an event only partially mirrored by anisomycin and ATP γS co-stimulation. early gene. Furthermore, this induction was mediated solely by the P2Y 2 receptor, since the P2Y 2 receptor agonists ATPγS Discussion and UTP, but not the P2Y 1 , P2Y 4 , P2Y 6 or P2X receptor agonists, gave rise to robust c-fos gene expression. Activation Our previous studies have demonstrated that MCF-7 cells express P2Y 2 receptors and proliferate in response to both of c-fos is particularly relevant in the MCF-7 breast cancer model, since expression of fos antisense RNA blocks MCF-7 ATP and UTP (5). These studies extend our previous observations and address the mechanisms underlying the proliferative tumour growth in nude mice (11) . Our observation that ATP induces c-fos expression is consistent with this model and completely abolished c-fos gene expression ( Figure 5 ), indicating that EGF-induced CREB phosphorylation is dependent significant in the context of the strong mitogenic effect of nucleotides on MCF-7 cells in culture.
ATP and EGF co-stimulation results in hyperphosphorylation
upon ERK activation, most likely via ERK-mediated activation of the CREB kinase, RSK2 (17). Co-stimulation with ATP γS Our previous demonstration that ATP potentiates c-fos transcription induced by systemic hormones in transformed and EGF gave rise to increased levels of both CREB and ERK phosphorylation relative to those seen with either agonist alone cells (10) prompted us to assess the ability of ATP γS to modulate growth-factor-induced c-fos expression in MCF- 7 and resulted in hyperphosphorylation of TCF. It is unclear at this stage to what extent individual components contribute cells. The results from co-stimulation with ATP γS and activators of different signalling cascades offer insight into the key toward the observed signalling synergy. However, on removal of the MAPK signalling component following MEK inhibition, pathways involved in ATP mediated-potentiation of growth factors and other environmental stimuli. Firstly, the effects of levels of transcription in response to ATP γS and EGF were still significantly higher than ATPγS alone. These data suggest ATP γS and Ca 2ϩ ionophore on c-fos induction were additive, suggesting that different signalling roles exist for calcium that pathway(s) other than growth factor receptor transactivation, MAPK and ATP-activated CREB contribute to the mobilized from intracellular pools (ATP γS) compared with extracellular calcium influx (calcium ionophore). The signalling synergy between nucleotides and growth ligand interaction results in the activation of several signalling pathways converging upon the c-fos promoter, one targeting factors clearly involves multiple components, a conclusion that concurs with the results from transgenic mice (22) , and the CaCRE via CREB phosphorylation on Ser133 and the other involving activation of the SRE principally through our in vitro experiments in cultured cells (10) , both of which indicate that multiple elements of the c-fos promoter must be the ERK cascade. In neuronal cells, P2Y 2 receptor-activated MAPK signalling results from calcium-dependent trans-activatargeted in order to achieve high levels of activation. These data strongly suggest that ATP serves as a potentiator for a tion of growth factor receptors (16), PYK2 activation (6) and subsequent ERK phosphorylation (6,16). We have clearly wide variety of signals known to have strong effects on cell proliferation, including growth factors (EGF), tumour shown, using anti-active transcription factor-specific antibodies in western analysis, that P2Y 2 activation in MCF-7 cells leads promoters (TPA) and stress (anisomycin). This function extends to activation of genes regulating the cell cycle at later stages, to ERK1 and ERK2 phosphorylation. However, ATP or UTP activation alone did not result in EGF receptor phosphorylation since ATP induces the late G 1 gene cyclin A and thereby promotes anchorage-independent cell growth (23). Since in these cells ( Figure 6 ). The pathways that couple ATP and UTP stimulation to activated ERK in MCF-7 cells are therefore anchorage-independence is a characteristic of transformed cells and a prerequisite for metastasis, ATP may also potentiate unclear. Whilst nucleotide stimulation alone did not lead to EGF receptor phosphorylation, co-stimulation of MCF-7 cells tumour progression. For ATP to influence neoplastic progression, it must exist with nucleotides and EGF resulted in higher levels of growth factor receptor phosphorylation than stimulation with EGF in sufficient concentrations in the vicinity of the tumour to activate cell surface P2Y 2 receptors. Transient high local ATP alone. It therefore appears that lateral signalling through growth factor receptor phosphorylation plays an important role in the concentrations can exist in the extracellular environment as a result of cell lysis during ischaemia, necrosis or as a result of synergic activation of gene expression observed in these studies.
inflammation or lysis by cytotoxic or NK cells. In addition, we and others have demonstrated that a non-lytic mechanism As a major nuclear target for activated ERK, TCF is similarly phosphorylated in response to ATP γS, an event implicating for ATP release exists in primary and transformed cells (24-26). It is therefore possible that breast cancer cells release the SRE in transcriptional activation. Furthermore, consistent with phosphorylation of TCF by nucleotides, Elk-1, the major ATP in vivo. Non-lytic ATP release may be particularly significant in the breast cancer model since a high intracellular component of human TCF, was similarly phosphorylated in response to nucleotide treatment. ATP γS-induced c-fos nucleotide concentration in transformed cells has been reported (27) . The P2Y 2 receptor itself may play an important regulatory expression was only partially attenuated by the MEK inhibitors U0126 or PD98059. Accordingly, ATP γS was effective at role, since non-lytic ATP release appears to be regulated, with UTP positively stimulating ATP release in a number of cell inducing CREB phosphorylation independently of MAPK activation. These data demonstrate that in MCF-7 cells, as in types (24). A frequent complication in breast cancer is cancer cell human osteoblasts, ATP can activate multiple c-fos promoter elements via the independent activation of several distinct invasion into bone. The high incidence of metastasis may be a reflection of a bone microenvironment suited to the further intracellular signalling pathways.
EGF, as expected, induced phosphorylation of both ERK growth of these tumour cells. A variety of growth factors and other extracellular agents that are present in bone are likely to and TCF and, like ATPγS, induced activation of CREB. However, inhibition of EGF-induced signalling with U0126
create conditions supporting cancer cell growth. Of these, ATP phosphatidylinositol 3-kinase and is independent of mitogen-activated may be significant since human osteoblasts can release ATP 
